H-021
/ Carephar Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 06, 2025
Evaluation of the tolerability, safety and preliminary efficacy of H021 tablets in patients with ulcerative colitis: a multicenter, open, single-arm phase Ic clinical trial
(ChiCTR)
- P1 | N=8 | Not yet recruiting | Sponsor: Gansu province people hospital; Jiangsu Carephar Pharmaceutical Co., Ltd
New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
April 02, 2025
A Randomized, Double-Blind, Placebo-Controlled Phase Ib Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Multiple Doses of H021 Tablets in Healthy Adult Subjects
(ChiCTR)
- P1 | N=10 | Not yet recruiting | Sponsor: The Second Affiliated Hospital of Soochow University; Jiangsu Carephar Pharmaceutical Co., Ltd
New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
1 to 2
Of
2
Go to page
1